Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk

Akshat Agrawal1, Brooke Scardino2, Diensn G Xing2

  • 1Department of Public Health, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, United States.

Insights

Stimulant use, including methamphetamine and cocaine, is linked to a higher risk of heart failure with reduced ejection fraction (HFrEF). This study found stimulant users are more likely to develop HFrEF than HFpEF.

Area of Science:

  • Cardiology
  • Public Health
  • Toxicology

Background:

  • Stimulant use (methamphetamine, cocaine) is a known risk factor for heart failure (HF).
  • Previous research has not specified HF subtypes associated with stimulant use.
  • This study investigates the association between stimulant use and HF subtypes, specifically HFrEF versus HFpEF.

Purpose of the Study:

  • To test the hypothesis that stimulant users have a higher likelihood of developing HFrEF compared to HFpEF.
  • To compare demographic characteristics and comorbidities between HF subtypes in stimulant users.
  • To identify patient populations at higher risk for stimulant-related HF.

Main Methods:

  • Utilized National Inpatient Sample data from 2008-2020 for hospital admissions of stimulant users with HF.
  • Employed chi-square and t-tests for categorical and continuous variables, respectively.
  • Used generalized linear models to determine HF subtype association with stimulant use, adjusting for traditional risk factors.

Main Results:

  • Stimulant use showed a higher association with HFrEF (OR=1.97) than HFpEF (OR=0.96).
  • HF among stimulant users was prevalent in males, aged 41-64, Black patients, Medicaid users, lower income groups, and in the South/West regions.
  • Stimulant-related HF hospitalizations significantly increased from 2008-2020 across all subcategories.

Conclusions:

  • Stimulant use is positively associated with HFrEF, particularly in middle-aged, male, Black individuals, and those with Medicaid.
  • The increased prevalence of traditional HF risk factors in stimulant-related HF supports multifactorial cardiovascular damage.
  • Findings highlight specific demographic groups at elevated risk for stimulant-associated heart failure.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
26
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
45
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
29
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
140